News

With this approval, FluMist becomes the first vaccine to prevent influenza that does not need to be administered by a health care provider.

The approval is indicated for adults and children aged 2 years and older, making arimoclomol (Miplyffa) the first drug approved by the FDA to treat NPC.

Those with inpatient food insecurity had an increased length of stay, as well as increased odds of readmission.

In this analysis, the differences in adverse events resulting from JAKi among adults and children were evaluated.

Infigratinib has also received Orphan Drug Designation, Fast Track Designation, and Rare Pediatric Disease Designation from the FDA.

Investigators found the association for higher BMI, increased obesity risk, and increased severe obesity risk.

Preadolescent sleep disturbances were linked to an increased risk of suicidal thoughts and behaviors in early adolescence, highlighting sleep as a key intervention target.

First-generation antihistamine prescriptions were linked to a 22% higher seizure risk in young children, especially those aged 6 to 24 months, according to recent findings.

According to findings, more consideration for individual differences in adverse experiences is needed for targeted interventions.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.

The indication is supported by trial data showing three-fourths of successfully treated patients maintained clear skin through 1 year of a lebrikizumab regimen.

A new study suggests an early AI-powered algorithm could help accurately identify common movements exhibited by children with autism spectrum disorder.

The CDC committee has set new recommendations based on children's age, vaccination status, and overall immunity health, for the 2024 - 2025 period.

Findings from a newly-published study revealed that newborn metabolic profiles may identify infants at an increased risk for SIDS shortly after birth.

Linda DiMeglio, MD, MPH, joined us to discuss the “Consensus Guidance for Monitoring Persons with Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes."

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to talk PGHD and the role of the pediatrician when it comes to treatment.

Can you diagnose this adolescent with an 11-day history of diffuse targetoid and bullous lesions on his extremities and trunk?

Alan Percy, MD, discusses where the general provider comes in when treating Rett syndrome and prescribing trofinetide (Daybue).

"The quest for a cure for colic continues," noted Jon Matthew Farber, MD.

Investigators concluded that findings suggest the need for improved public health messaging regarding fish intake guidelines for pregnant persons.

In this last episode, our panel discusses this patient population and the challenges around keeping them in the continuum of care.

Availability for the type 1 allergic reactions treatment approved by the FDA in August is expected later this month.

Alan Percy, MD, discussed what the FDA approval of trofinetide (Daybue) has meant to patients with Rett syndrome aged 2 years and older.

As providers, it’s imperative to reward engagement and build on the successes of the professionals who invest their time and talent into the mission of our organization.

Screen time before bed did not impair sleep in children, but in-bed use demonstrated delayed sleep onset and reduced total sleep time.

"This is another example of how people trying to find a useful therapeutic role for magnesium usually come up short," stated Jon Matthew Farber, MD.